news-med.jpg

Evotec receives milestone payment for start of Phase II clinical trial

Evotec's partner, Second Genome, begins a Phase II Clinical trial for NASH with licensed molecule,

Topics: Corporate, Evotec, Second Genome, Microbiome, NASH Read More

Most Read

Posts by Topic